查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1300988

北美脫髮市場規模、份額和趨勢分析報告：按治療（藥物、設備）、按疾病類型（斑禿）、按最終用途、按銷售渠道、按性別、按國家、按細分市場、2023 年預測～ 2030年

North America Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, Devices), By Disease Type (Alopecia Areata), By End-use, By Sales Channel, By Gender, By Country, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

北美脫髮市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，2023 年至 2030 年北美脫髮市場規模將以 7.5% 的複合年增長率增長，預計將達到56.5億美元。

預計該市場將受到治療技術進步和脫髮相關疾病患病率上升的共同推動。 此外，大公司的各種戰略舉措，例如光療法和其他藥物開發，預計也將在預測期內推動增長。

在北美脫髮行業，由於有影響力的市場進入者的存在，競爭對手之間的競爭預計將持續激烈。 品牌藥的仿製藥進一步加劇了商業競爭。 主要參與者參與針對臨床需求未滿足人群的新型治療方法和藥物的開發。 例如，Cassiopea S.p.A. 正在開發一種治療女性男性型禿髮的藥物。

國家斑禿基金會 (NAAF)、加拿大斑禿基金會和疤痕性禿髮研究基金會等組織支持治療研究和開發以及產品開發。我們正在推動資助 例如，國家斑禿基金會 (NAAF) 為研究人員提供研究補助金和資金。 迄今為止，該組織已提供 208 項研究資助，總計約 570 萬美元，用於支持疾病病理生理學、免疫途徑和靶向治療開發的研究。

此外，領先機構為縮小毛髮疾病研究差距而持續資助的計劃可能會促進市場擴張。 例如，2021年4月，美國皮膚病學會宣布啟動脫髮和脫髮研究倡議（HAIR）資助計劃。 HAIR 計劃為美國的研究人員、實習生和皮膚科醫生提供資金，以完成研究項目，開發針對頭髮疾病的新穎解決方案。

此外，監管部門的批准和主要參與者的各種戰略舉措預計將推動增長。 例如，2022年6月，Incyte和禮來公司宣布OLUMIANT（baricitinib）獲得美國FDA批准用於成人嚴重AA的全身治療。 Olmiant 有 1 毫克、2 毫克和 4 毫克片劑可供選擇。 此外，2020 年 4 月，ITO Biosciences 宣布推出男性和女性非處方藥米諾地爾。 該產品適用於脫髮恢復，可通過該公司的全資子公司 Innovus Pharmaceuticals 購買。

北美脫髮市場報告亮點

  • 就治療劑而言，由於藥品的廣泛供應和新型治療劑的存在，製藥領域在北美脫髮行業中佔有最大份額。
  • 由於對嚴重脫髮的認識提高，預計普禿將創下按疾病類型劃分的最高複合年增長率
  • 從最終用途來看，激光技術等現代治療方法的出現以及醫生和皮膚科醫生就診次數的增加將使皮膚科診所部門在 2022 年主導北美脫髮行業。
  • 到 2022 年，男性細分市場所佔份額最大，而女性細分市場預計在預測期內將以最高複合年增長率增長。
  • 主要市場公司包括 Pfizer Inc、Eli Lilly and Company、Merck & Co., Inc、Concert Pharmaceuticals、Curallux, LLC、PureTech、Freedom Laser Therapy, Inc、LUTRONIC、HCW Biologics Inc、Curallux, LLC 等。是。

內容

第一章調查方法及範圍

  • 市場細分和範圍
    • 段定義
    • 細分市場和區域覆蓋範圍
    • 估計/預測時間表
  • 調查方法
  • 信息獲取
    • 購買的數據庫：
    • Gvr 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的詳細信息
  • 信息或數據分析
    • 數據分析模型
  • 市場形成和驗證
  • 型號詳細信息
    • 產品流分析
  • 調查假設
  • 輔助信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場概況
  • 片段快照
    • 競爭格局快照

第 3 章北美脫髮市場變量、趨勢和範圍

  • 市場體系展望
    • 母公司市場前景
    • 輔助市場展望
  • 繪製採用率和增長前景圖
  • 監管狀況
  • 市場動態
    • 市場驅動因素分析
    • 市場製約因素分析
  • 脫髮：市場分析工具
    • 行業分析 - Porters -（藥品）
    • 行業分析 - 搬運工（設備）
    • 按因素（政治/法律、經濟/技術）進行 SWOT 分析（製藥）
    • SWOT 分析，按要素（政治/法律、經濟/技術）（設備）
  • 管道分析

第 4 章北美脫髮市場：2018-2030 年按疾病類型劃分的細分市場分析（百萬美元）

  • 北美脫髮市場：疾病類型變化分析
    • 2018-2030 年市場規模、預測、趨勢分析
    • 斑禿
    • 疤痕性脫髮
    • 牽引性脫髮
    • 全禿
    • 普禿
    • 男性型禿髮
    • 其他

第 5 章北美脫髮市場：按治療方式細分分析，2018-2030 年（百萬美元）

  • 北美脫髮市場：治療波動分析
  • 2018-2030年市場規模、預測及趨勢分析
    • 藥品
    • 設備

第 6 章北美脫髮市場：細分分析，性別，2018-2030 年（百萬美元）

  • 北美脫髮市場：性別差異分析
  • 2018-2030 年市場規模、預測、趨勢分析
    • 男性
    • 女性

第 7 章：北美脫髮市場：細分分析，按最終用途，2018-2030 年（百萬美元）

  • 北美脫髮市場：最終用途變化分析
  • 2018-2030 年市場規模、預測、趨勢分析
    • 家庭護理環境
    • 皮膚科診所

第 8 章北美脫髮市場：2018-2030 年按地區劃分的細分市場分析（百萬美元）

  • 脫髮市場：按國家/地區劃分的差異分析
  • 2022 年和 2030 年區域市場份額分析
  • 2018-2030 年市場規模、預測、收入和趨勢分析
    • 北美

第9章北美脫髮市場：競爭分析（藥品）

  • 主要市場進入者的最新趨勢和影響分析
    • 推出新產品
    • 併購
    • 合資企業
    • 合作夥伴和許可協議
    • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
    • 熱圖分析
  • 供應商情況
    • 主要分銷商和渠道合作夥伴名單
    • 主要客戶
  • 上市公司
    • 2022 年主要參與者的市場份額分析
    • 企業市場分析
    • 競爭儀表板分析
  • 私人公司
    • 主要初創企業名單
  • 公司簡介（藥品）
    • 西普拉有限公司
    • 太陽製藥工業有限公司
    • 強生服務公司
    • 默克公司
    • 列剋星敦國際有限責任公司
    • Cirrus 頭髮中心
    • VITA-COS-MED KLETT-LOCH GMBH
    • 過渡頭髮
    • 純科技健康
    • CURALLUX 有限責任公司
    • 雷迪博士實驗室有限公司
    • 葛蘭素史克 (GSK)
    • Aurobindo 製藥公司
    • MYLAN NV（VIATRIS, INC.）

第10章北美脫髮市場：競爭分析（設備）

  • 主要市場進入者的最新趨勢和影響分析
    • 主要交易和戰略聯盟分析
  • 公司分類
    • 創新者
    • 市場領導者
    • 熱圖分析
  • 供應商情況
    • 主要經銷商和渠道合作夥伴名單
    • 主要客戶
  • 上市公司
    • 競爭儀表板分析
    • 2022 年公司市場份額分析（設備）
  • 私人公司
    • 主要初創企業名單
  • 公司簡介（設備）
    • FREEDOM LASER THERAPY, INC.
    • APIRA SCIENCE, INC.（IGROW LASER.）
    • REVIAN, INC
    • THERADOME INC.
    • LUTRONIC INC.
    • WON TECH CO., LTD
    • LIFEMD
    • LG ELECTRONICS
Product Code: GVR-4-68040-083-4

North America Alopecia Market Growth & Trends

The North America alopecia market size is expected to reach USD 5.65 billion by 2030, expanding at a 7.5% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to be collectively driven by technological advancements in treatments, and the rise in the prevalence of diseases associated with hair loss. Moreover, various strategic initiatives undertaken by leading players such as the development of light-based treatment and other pharmaceutical products developments are also anticipated to propel growth forward during the projected period.

The competitive rivalry in North America alopecia industry is likely to remain high due to the presence of prominent market participants. Generic copies of branded drugs further intensify commercial competition. Key players are involved in the development of novel therapies or drugs, to target people with unmet clinical needs. For instance, Cassiopea S.p.A. is engaged in the development of treatment for female androgenetic alopecia, as there is no drug approved for this particular indication.

Organizations, such as National Alopecia Areata Foundation (NAAF), Canadian Alopecia Areata Foundation, and Cicatricial Alopecia Research Foundation, among others, promote funding to support R&D and product development exercises pertaining to the treatment. For instance, National Alopecia Areata Foundation (NAAF) provides research grants and funding to researchers. To date, the organization has provided 208 research grants, totaling around USD 5.7 million, to sponsor studies on the pathophysiology of diseases, immune pathways, and developing targeted treatments.

Moreover, ongoing funding programs by leading organizations to decrease the gaps in hair disorders research is likely to expedite market expansion. For instance, in April 2021, the American Academy of Dermatology Association announced the launch of the Hair Loss and Alopecia Initiative in Research (HAIR) funding program. Under this HAIR program funding will be offered to researchers, trainees, and dermatologists in the U.S. for completing research projects for the development of novel solutions for hair disorders.

Furthermore, regulatory approvals and various strategic initiatives undertaken by leading players are expected to propel growth forward. For instance, in June 2022, Incyte and Eli Lilly and Company announced that OLUMIANT (baricitinib) received approval from the U.S. FDA for systemic treatment for adults with severe AA. OLUMIANT pill is available in 1 mg, 2 mg, and 4 mg tablets. In addition, in April 2020 Aytu BioScience, Inc. announced the launch of OTC foam formulation of minoxidil for men and women. This product is indicated for reversing hair loss and is available through the company's wholly-owned subsidiary Innovus Pharmaceuticals.

North America Alopecia Market Report Highlights

  • By treatment, the pharmaceutical segment held the largest share of the North America alopecia industry due to the widespread availability of pharmaceutical products, and the presence of novel therapeutics
  • The alopecia universalis segment is expected to register the highest CAGR rate in disease type segment owing to increasing awareness about severe forms of AA
  • By end-use, the dermatology clinics segment held the largest share of the North America alopecia industry in 2022 owing to the availability of modern treatment methods such as laser technology and increasing visits to doctors & dermatologists
  • The male gender segment held the largest share in 2022, whereas, the female gender segment is expected to register the highest CAGR rate during the forecast period
  • Some of the key market players include Pfizer Inc; Eli Lilly and Company; Merck & Co., Inc; Concert Pharmaceuticals; Curallux, LLC; PureTech; Freedom Laser Therapy, Inc; LUTRONIC; HCW Biologics Inc; Curallux, LLC; and others.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definition
    • 1.1.2 Segment & Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
      • 2.3.Competitive Landscape Snapshot

Chapter 3 North America Alopecia Market Variables, Trends, and Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Regulatory Landscape
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increasing Prevalence Of Alopecia
      • 3.4.1.2 Increasing Healthcare Expenditure
      • 3.4.1.3 Increasing Prevalence Of Chronic Diseases
      • 3.4.1.4 Technological Advancements In Alopecia Treatment
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 Lack Of Reimbursement Policies For Alopecia Treatment
      • 3.4.2.2 Increasing Adoption Of Substitutes
  • 3.5 Alopecia: Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's - (Pharmaceuticals)
    • 3.5.2 Industry Analysis - Porter's (Devices)
    • 3.5.3 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Pharmaceuticals)
    • 3.5.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological) (Devices)
  • 3.6 Pipeline Analysis

Chapter 4 North America Alopecia Market: Segment Analysis, By Disease Type, 2018 - 2030 (USD Million)

  • 4.1 North America Alopecia Market: Disease Type Movement Analysis
    • 4.1.1 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 4.1.2 Alopecia Areata
      • 4.1.2.1 Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.2 Male Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.2.3 Female Alopecia Areata Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.3 Cicatricial Alopecia
      • 4.1.3.1 Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.2 Male Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.3.3 Female Cicatricial Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.4 Traction Alopecia
      • 4.1.4.1 Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.2 Male Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.4.3 Female Traction Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.5 Alopecia Totalis
      • 4.1.5.1 List Of Organizations
      • 4.1.5.2 Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.3 Male Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.5.4 Female Alopecia Totalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.6 Alopecia Universalis
      • 4.1.6.1 Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.2 Male Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.1.6.3 Female Alopecia Universalis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.1.7 Androgenetic Alopecia
      • 4.1.7.1 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.2 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.7.3 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
    • 4.1.8 OTHERS
      • 4.1.8.1 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.2 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
      • 4.1.8.3 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 North America Alopecia Market: Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 5.1 North America Alopecia Market: Treatment Movement Analysis
  • 5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.2.1 Pharmaceuticals
      • 5.2.1.1 Pharmaceuticals Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2 Topical Drugs
      • 5.2.1.2.1 Topical Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2 Topical Otc Drugs
      • 5.2.1.2.2.1 Topical Otc Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.2 Minoxidil
      • 5.2.1.2.2.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.2.3 Other Otc Drugs
      • 5.2.1.2.2.3.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3 Topical Prescription Drugs
      • 5.2.1.2.3.1 Topical Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.2 Betamethasone Dipropionate
      • 5.2.1.2.3.2.1 Betamethasone Dipropionate Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.3 Fluocinolone Acetonide
      • 5.2.1.2.3.3.1 Fluocinolone Acetonide Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.4 Finasteride
      • 5.2.1.2.3.4.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2.3.5 Minoxidil
      • 5.2.1.2.3.5.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3 Oral Drugs
      • 5.2.1.3.1 Oral Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.2 Oral Otc Drugs
      • 5.2.1.3.2.1 Oral Otc Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3 Oral Prescription Drugs
      • 5.2.1.3.3.1 Oral Prescription Drugs Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.2 Minoxidil
      • 5.2.1.3.3.2.1 Minoxidil Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.3 Finasteride
      • 5.2.1.3.3.3.1 Finasteride Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.3.3.4 Oral Corticosteroids
      • 5.2.1.3.3.4.1 Oral Corticosteroids Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.4 Platelet - Rich Plasma Injections
      • 5.2.1.4.1 Platelet - Rich Plasma Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Devices
      • 5.2.2.1 Devices Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.2 Laser Cap
      • 5.2.2.2.1 Laser Cap Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.3 Laser Comb
      • 5.2.2.3.1 Laser Comb Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.2.4 Laser Helmet
      • 5.2.2.4.1 Laser Helmet Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 North America Alopecia Market: Segment Analysis, By Gender, 2018 - 2030 (USD Million)

  • 6.1 North America Alopecia Market: Gender Movement Analysis
  • 6.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 6.2.1 Male
      • 6.2.1.1 Male Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Female
      • 6.2.2.1 Female Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 North America Alopecia Market: Segment Analysis, By End - Use, 2018 - 2030 (USD Million)

  • 7.1 North America Alopecia Market: End - Use Movement Analysis
  • 7.2 Market Size & Forecasts And Trend Analyses, 2018 To 2030
    • 7.2.1 Homecare Settings
      • 7.2.1.1 Homecare Settings Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Dermatology Clinics
      • 7.2.2.1 Dermatology Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 North America Alopecia Market: Segment Analysis, By Region, 2018 - 2030 (USD Million) (Number Of Patients, In Thousands)

  • 8.1 Alopecia Market: Country Movement Analysis
  • 8.2 Regional Market Share Analysis, 2022 & 2030
  • 8.3 Market Size, & Forecasts, Revenue And Trend Analysis, 2018 To 2030
    • 8.3.1 North America
      • 8.3.1.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.2 U.S.
      • 8.3.1.2.1 U.S. Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.3.1.3 Canada
      • 8.3.1.3.1 Canada Alopecia Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 North America Alopecia Market: Competitive Analysis (Pharmaceuticals)

  • 9.1 Recent Developments And Impact Analysis, By Key Market Participants
    • 9.1.1 New Product Launches
    • 9.1.2 Mergers And Acquisitions
    • 9.1.3 Joint Venture
    • 9.1.4 Partnerships And Licensing Agreements
    • 9.1.5 Conferences And Campaigns
  • 9.2 Company Categorization
    • 9.2.1 Innovators
    • 9.2.2 Market Leaders
    • 9.2.3 Heat Map Analysis
  • 9.3 Vendor Landscape
    • 9.3.1 List Of Key Distributors And Channel Partners
    • 9.3.2 Key Customers
  • 9.4 Public Companies
    • 9.4.1 Key Company Market Share Analysis, 2022
    • 9.4.2 Company Market Position Analysis
    • 9.4.3 Competitive Dashboard Analysis
      • 9.4.3.1 Market Differentiators
  • 9.5 Private Companies
    • 9.5.1 List Of Key Emerging Companies
  • 9.6 Company Profiles (Pharmaceuticals)
    • 9.6.1 CIPLA LIMITED
      • 9.6.1.1 Company overview
      • 9.6.1.2 Financial Performance
      • 9.6.1.3 Product benchmarking
    • 9.6.2 SUN PHARMACEUTICALS INDUSTRIES LTD.
      • 9.6.2.1 Company overview
      • 9.6.2.2 Financial Performance
      • 9.6.2.3 Product benchmarking
      • 9.6.2.4 Strategic initiatives
    • 9.6.3 JOHNSON & JOHNSON SERVICES, INC.
      • 9.6.3.1 Company overview
      • 9.6.3.2 Financial Performance
      • 9.6.3.3 Product benchmarking
      • 9.6.3.4 Strategic initiatives
    • 9.6.4 MERCK & CO., INC.
      • 9.6.4.1 Company overview
      • 9.6.4.2 Financial Performance
      • 9.6.4.3 Product benchmarking
      • 9.6.4.4 Strategic initiatives
    • 9.6.5 LEXINGTON INTL., LLC
      • 9.6.5.1 Company overview
      • 9.6.5.2 Product benchmarking
    • 9.6.6 CIRRUS HAIR CENTERS
      • 9.6.6.1 Company overview
      • 9.6.6.2 Financial Performance
      • 9.6.6.3 Product benchmarking
    • 9.6.7 VITA - COS - MED KLETT - LOCH GMBH
      • 9.6.7.1 Company overview
      • 9.6.7.2 Product benchmarking
    • 9.6.8 TRANSITIONS HAIR
      • 9.6.8.1 Company overview
      • 9.6.8.2 Product benchmarking
    • 9.6.9 PURETECH HEALTH
      • 9.6.9.1 FOLLICA, INC.
      • 9.6.9.1.1 Company overview
      • 9.6.9.2 Financial Performance
      • 9.6.9.3 Product benchmarking
      • 9.6.9.4 Strategic initiatives
    • 9.6.10 CURALLUX, LLC
      • 9.6.10.1 Company overview
      • 9.6.10.2 Product benchmarking
      • 9.6.10.3 Strategic initiatives
    • 9.6.11 DR. REDDY'S LABORATORIES LTD
      • 9.6.11.1 Company overview
      • 9.6.11.2 Financial Performance
      • 9.6.11.3 Product benchmarking
      • 9.6.11.4 Strategic initiatives
    • 9.6.12 GLAXOSMITHKLINE PLC (GSK)
      • 9.6.12.1 Company overview
      • 9.6.12.2 Financial Performance
      • 9.6.12.3 Product benchmarking
    • 9.6.13 AUROBINDO PHARMA
      • 9.6.13.1 Company overview
      • 9.6.13.2 Financial Performance
      • 9.6.13.3 Product benchmarking
    • 9.6.14 MYLAN N.V. (VIATRIS, INC.)
      • 9.6.14.1 Company overview
      • 9.6.14.2 Financial Performance
      • 9.6.14.3 Product benchmarking
      • 9.6.14.4 Strategic initiatives

Chapter 10 North America Alopecia Market: Competitive Analysis (Devices)

  • 10.1 Recent Developments and Impact Analysis, by Key Market Participants
    • 10.1.1 Major Deals And Strategic Alliances Analysis
      • 10.1.1.1 New Product Launches
      • 10.1.1.2 Partnerships and Licensing Agreements
      • 10.1.1.3 Conferences and Campaigns
  • 10.2 Company Categorization
    • 10.2.1 Innovators
    • 10.2.2 Market Leaders
    • 10.2.3 Heat Map Analysis
  • 10.3 Vendor Landscape
    • 10.3.1 List Of Key Distributors And Channel Partners
    • 10.3.2 Key Customers
  • 10.4 Public Companies
    • 10.4.1 Competitive Dashboard Analysis
      • 10.4.1.1 Market Differentiators
    • 10.4.2 Company Market Share Analysis (Devices), 2022
  • 10.5 Private Companies
    • 10.5.1 List Of Key Emerging Companies
  • 10.6 Company Profiles (Devices)
    • 10.6.1 FREEDOM LASER THERAPY, INC.
      • 10.6.1.1 Company overview
      • 10.6.1.2 Product benchmarking
      • 10.6.1.3 Strategic initiatives
    • 10.6.2 APIRA SCIENCE, INC. (IGROW LASER.)
      • 10.6.2.1 Company overview
      • 10.6.2.2 Product benchmarking
      • 10.6.2.3 Strategic initiatives
    • 10.6.3 REVIAN, INC
      • 10.6.3.1 Company overview
      • 10.6.3.2 Product benchmarking
      • 10.6.3.3 Strategic initiatives
    • 10.6.4 THERADOME INC.
      • 10.6.4.1 Company overview
      • 10.6.4.2 Product benchmarking
      • 10.6.4.3 Strategic initiatives
    • 10.6.5 LUTRONIC INC.
      • 10.6.5.1 Company overview
      • 10.6.5.2 Product benchmarking
      • 10.6.5.3 Strategic initiatives
    • 10.6.6 WON TECH CO., LTD
      • 10.6.6.1 Company overview
      • 10.6.6.2 Product benchmarking
      • 10.6.6.3 Strategic initiatives
    • 10.6.7 LIFEMD
      • 10.6.7.1 Company overview
      • 10.6.7.2 Product benchmarking
      • 10.6.7.3 Strategic initiatives
    • 10.6.8 LG ELECTRONICS
      • 10.6.8.1 Company overview
      • 10.6.8.2 Product benchmarking
      • 10.6.8.3 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 List of late-stage clinical trials
  • Table 5 Approved generic version of Avodart:
  • Table 6 Androgenetic alopecia in men and women
  • Table 7 List of parameters
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of key distributors
  • Table 10 Key company market share (%)
  • Table 11 List of parameters
  • Table 12 Leading market players anticipated to witness highest growth
  • Table 13 List of other distributors
  • Table 14 Key company market share (%)
  • Table 15 North America Alopecia Market, By Country, 2018 - 2030 (USD Million)
  • Table 16 North America Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 17 North America Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 18 North America Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 19 North America Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 20 North America Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 21 U.S. Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 22 U.S. Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 23 U.S. Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 24 U.S. Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 25 U.S. Alopecia Market, By Gender, 2018 - 2030 (USD Million)
  • Table 26 Canada Alopecia Market, By Treatment, 2018 - 2030 (USD Million)
  • Table 27 Canada Alopecia Market, By Disease Type, 2018 - 2030 (USD Million)
  • Table 28 Canada Alopecia Market, By End-Use, 2018 - 2030 (USD Million)
  • Table 29 Canada Alopecia Market, By Sales Channel, 2018 - 2030 (USD Million)
  • Table 30 Canada Alopecia Market, By Gender, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America alopecia market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews, by type
  • Fig. 6 Primary interviews, by country
  • Fig. 7 Market research approaches
  • Fig. 8 Value - chain - based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Market outlook (2022)
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 Porter's five forces analysis, Devices
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 SWOT analysis, by factor (political & legal, economic, and technological), Devices
  • Fig. 19 North America alopecia market disease type outlook: Key takeaways
  • Fig. 20 North America alopecia market: Disease type movement analysis
  • Fig. 21 Alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Male alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Female alopecia areata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Male cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Female cicatricial alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Male traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Female traction alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Male alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Female alopecia totalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Male alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Female alopecia universalis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Male androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Female androgenetic alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Male other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Female other alopecia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 North America Alopecia market treatment outlook: Key Takeaways
  • Fig. 43 Alopecia market: Treatment movement analysis
  • Fig. 44 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Topical drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Topical OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Topical prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Betamethasone dipropionate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Fluocinolone acetonide market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Oral drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Oral OTC drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Oral prescription drugs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Minoxidil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Finasteride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Oral corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Platelet - rich plasma market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Laser cap market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Laser comb market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Laser helmet market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 North America Alopecia market gender outlook: Key takeaways
  • Fig. 66 North America Alopecia market: Gender movement analysis
  • Fig. 67 Male market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Female market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 North America Alopecia market end - use outlook: Key takeaways
  • Fig. 70 North America Alopecia market: end - use movement analysis
  • Fig. 71 Homecare settings market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 73 North America Alopecia market sales channel outlook: Key takeaways
  • Fig. 74 North America Alopecia market: Sales channel movement analysis
  • Fig. 75 Prescriptions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Regional outlook, 2022 & 2030
  • Fig. 78 North America
  • Fig. 79 North America alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 80 U.S.
  • Fig. 81 U.S. alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 82 Canada
  • Fig. 83 Canada alopecia market estimates and forecast, 2018 - 2030 (USD Million) (Number of Patients, in Thousands)
  • Fig. 84 Heat map analysis
  • Fig. 85 Company market position analysis (2022)
  • Fig. 86 Company market position analysis (2022)
  • Fig. 87 Market differentiators
  • Fig. 88 Strategy mapping
  • Fig. 89 Heat map analysis
  • Fig. 90 Market differentiators